Showing results (81-90 of 434) with videos related to
Sort By:
Pageof 44
Cancer Prevention Research (Philadelphia, Pa.)|July 26, 2014
Convergence of nanotechnology and cancer prevention: are we there yet?David G Menter, Sherri L Patterson, Craig D Logsdon, et al.Cancer Metastasis Reviews|April 4, 2014
Platelets and cancer: a casual or causal relationship: revisitedDavid G Menter, Stephanie C Tucker, Scott Kopetz, et al.Journal of Cellular Physiology|April 3, 2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cellsTina Cascone, Maria Pia Morelli, Floriana Morgillo, et al.Carcinogenesis|April 17, 2012
GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomesJingyao Dai, Jian Gu, Maosheng Huang, et al.Biorxiv : the Preprint Server for Biology|September 16, 2024
Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS -mutated colorectal cancerSusmita Ghosh, Fan Fan, Reid Powell, et al.AJR. American Journal of Roentgenology|November 24, 2011
CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumabPiyaporn Boonsirikamchai, Mohamed Aly Asran, Dipen M Maru, et al.Oncotarget|February 11, 2016
Examining plasma microRNA markers for colorectal cancer at different stagesYan Sun, Yuexin Liu, David Cogdell, et al.Cancer Metastasis Reviews|July 22, 2017
Platelet "first responders" in wound response, cancer, and metastasisDavid G Menter, Scott Kopetz, Ernest Hawk, et al.BMC Cancer|September 12, 2014
Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancerScott Kopetz, Van K Morris, Nila Parikh, et al.Cancer Genetics|August 27, 2019
Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNAXuemei Shi, Dzifa Y Duose, Meenakshi Mehrotra, et al.Pageof 44